Form 4: InspireMD CEO Marvin Slosman Increases Stake in NSPR

CEO and President Marvin Slosman acquired 21,000 shares of InspireMD, Inc. common stock at $1.20 per share.

Summary

• Marvin Slosman, CEO and President of InspireMD, Inc., purchased 21,000 shares of common stock.
• The transaction occurred on May 12, 2026, at a price of $1.20 per share.
• Following this acquisition, the reporting person's total beneficial ownership increased to 3,556,658 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive indicator of management confidence, as the CEO is actively increasing his personal financial stake in the company.

Positives

• Insider confidence is demonstrated by the CEO's decision to increase his equity position in the company.
• The purchase of 21,000 shares indicates alignment between management and shareholder interests.

Negatives

• None noted in this filing.

Risks

• None noted in this filing.

Future Outlook

Not applicable.

Industry Context

StockSavvy.ai notes that insider buying by a CEO is generally viewed as a positive signal of management's belief in the company's long-term strategic direction and valuation.

Comparison to Industry Standards

• Insider purchases by C-suite executives are standard practice for demonstrating commitment to company performance.
• The volume of shares purchased is consistent with typical executive equity accumulation patterns.

Stakeholder Impact

• Shareholders may interpret this purchase as a sign of stability and confidence from the company's leadership.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

InspireMD, NSPR, Insider Trading, Form 4, Marvin Slosman, Equity Acquisition